$268.36+15% 1Y

Is the price fair?

Fair

Neither cheap nor expensive: modest expectations priced in, but at the top of its own P/E range and rich vs its sector.

1 good, 2 to watch
What the price assumes~+11% a yearderived · Mar 28, 2026

Priced for ~11% a year FCF growth. The price demands less than its three-year revenue growth of 16% a year, expectations look modest.

Vs its own P/E rangedearest in 34 quartersderived

Expensive vs its own history: P/E 29.9 vs a 18.5 median over 34 quarters (+62% vs median).

Vs sector (EV/EBIT)22.6×derived · Dec 27, 2025

Sector median 16.2× across 157 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)behind 68% of the market
FCF yieldbehind 69% of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What GRMN's price assumes

Garmin trades at 29.9× earnings against 38.2× for the median Scientific & Technical Instruments name, cheaper than its own group.

29.9

Trailing P/E · Scientific & Technical Instruments median 38.2 · cheaper than the typical name in its group

Price / sales
6.23

Price / sales · today's price, fiscal year to Dec 27, 2025

Free cash flow yield
3.2%

Free cash flow yield · Scientific & Technical Instruments median 4.0%

Growth the price implies
+11%

Growth the price implies · The price pays for +11% free cash flow growth a year for a decade; the business has delivered +31% a year over the last three.

Details›
Price / booktoday's price, fiscal year to Dec 27, 2025
5.03
EV / EBITtoday's price, fiscal year to Dec 27, 2025
22.6
EV / salestoday's price, fiscal year to Dec 27, 2025
5.86
Consumer Cyclical median P/E321 names
17.8
Scientific & Technical Instruments median P/E18 names
38.2
Free cash flow, trailing twelve months
$1.45B
Market capitalisation
$45.2B
3-year revenue growth
+16%
3-year free cash flow growth
+31%
What the market has paid for these earnings: 34 quarters of its own multiple × $8.96 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$137.90
Its own P/E history, median$165.54
Its own P/E history, upper quartile$191.81
52-week range$184.77 – $313.03
Today$268.36

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:R&D leaders